|
⚲
|
| Vitae Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001157602 |
| Sale | 2009-06-05 ($15.0 M Offered, $15.0 M Sold) |
| Fund | |
| Phone | 2154612000 |
| Address | 502 West Office Center Dr Fort Washington, 19034 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Charles Newhall | |
| Robert Gunderson | |
| James Tananbaum | |
| Tina Fiumenero | |
| Richard Gregg | |
| Peter Barrett | |
| Donald Hayden | |
| Bryan Roberts | |
| Jeffrey Hatfield |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Harborview Healthcare, Inc.
✚
|
0.0 | |
|
SYN 22 LP
✚
|
0.0 | |
|
Harp Angell, Inc.
✚
|
0.0 | |
|
ARIA Investment Partners V, LP
✚
|
0.0 | |
|
Arias Americo
✚
|
0.0 | |
|
AR II REIT, Inc.
✚
|
0.0 | |
|
Arise St Gregorys Beach LLC
✚
|
0.0 | |
|
Henley R Brian
✚
|
0.0 | |
|
Hg Asyst Co-Invest L.P.
✚
|
0.0 | |
|
Hann Gregory A
✚
|
0.0 |